• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, July 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

NCI awards $1.7 million to UIC for research on Southeast Asian fruit

Bioengineer by Bioengineer
January 17, 2019
in Cancer
Reading Time: 2 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers will investigate mangosteen fruit as potential treatment for prostate cancer

IMAGE

Credit: UIC/Arnold Diaz

For generations, traditional healers in Southeast Asia have used the mangosteen fruit to treat skin infections, wounds, dysentery and urinary tract infections. A new $1.7 million grant from the National Cancer Institute will enable researchers at the University of Illinois at Chicago to study the fruit and its potential as a treatment for prostate cancer.

Led by Dr. Jeremy Johnson, associate professor of pharmacy practice at the UIC College of Pharmacy, the researchers will expand on prior work, which identified phytochemicals in the fruit that can disrupt the function of the androgen receptor, a critical target in prostate cancer.

“Mangosteen contains unique xanthones, which are a type of antioxidant, that promote androgen receptor degradation,” Johnson said. “This mechanism has not been identified with any other compounds and this approach could help deal with the very serious and common problem of drug resistance with FDA-approved drugs for prostate cancer.”

In past studies, Johnson’s group reported that mice treated with their mangosteen extract had prostate tumors that were 88 percent smaller than tumors in a control group.

Over the course of five years, the new funding will enable researchers to study how specific xanthones in mangosteen inhibit androgen receptor activity in prostate cancer cells. Johnson, who has also worked as a pharmacist, and his team will study how orally administered mangosteen xanthones are absorbed in animal models; they later will conduct experiments to determine what dose of the mangosteen xanthones are most effective at preventing or treating prostate cancer, also in animal models.

Round with a deep purple outer layer that surrounds the white pulp fruit, mangosteen is cultivated primarily in Thailand and other Southeast Asian and Pacific Rim countries. A long history and folklore surround mangosteen, also referred to as the “Queen’s fruit,” for its unique flavor and medicinal benefits. Queen Victoria, who lived from 1819 to 1901, is said to have offered a cash award to anyone who could bring mangosteen back to England.

Many in the U.S. may not be familiar with the mangosteen fruit, Johnson said. It was not approved for import into the country until 2007 but he says it may be found in local Asian grocery stores or Chinatown.

Along with his research on mangosteen, Johnson and his laboratory are studying Mediterranean herbs – including rosemary – for inflammatory bowel disease and colitis.

###

Co-principal investigators on the grant, which was awarded by the NCI’s National Cancer Advisory Board as a MERIT Award, are Maarten Bosland, professor of pathology in the UIC College of Medicine, and Chun-Tao Che, the Harry H.S. Fong Professor of Pharmacognosy.

Media Contact
Jackie Carey
[email protected]
312-996-8277

Original Source

https://today.uic.edu/nci-awards-1-7-million-to-uic-for-research-on-southeast-asian-fruit

Tags: cancerMedicine/HealthProstate Cancer
Share12Tweet8Share2ShareShareShare2

Related Posts

EMT and Cancer: Essential Insights for Clinicians

EMT and Cancer: Essential Insights for Clinicians

July 26, 2025
Vepdegestrant Outperforms Fulvestrant in Mutant ER+ Breast Cancer

Vepdegestrant Outperforms Fulvestrant in Mutant ER+ Breast Cancer

July 26, 2025

Expanding MET’s Therapeutic Role in NSCLC and Beyond

July 26, 2025

Microbiota’s Role in Radiotherapy-Driven Cancer Immunity

July 26, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    48 shares
    Share 19 Tweet 12
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • New Measurements Elevate Hubble Tension to a Critical Crisis

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Durable, Flexible Electrochemical Transistors via Electropolymerized PEDOT

Challenges and Opportunities in High-Filled Polymer Manufacturing

Epicardial Fat: Protector or Threat to Heart Health?

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.